Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

A look at the strategies that will best address the challenges facing Medtech Corporate Communications in 2010.  
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

European regulators OK $13B Zimmer-Biomet deal

March 30, 2015 by Brad Perriello

Anti-trust regulators in the European Union approve the pending, $13.4 billion merger of orthopedic giants Zimmer Holdings and Biomet.

European regulators OK $13B Zimmer-Biomet deal

Olympus to pay $92m to settle accounting fraud case

March 27, 2015 by MassDevice

Olympus says it agreed to pay $92 million to settle a pair of civil lawsuits brought over the 2001 accounting scandal that nearly brought the company down.

Olympus to pay $92m to settle accounting fraud case

Obalon launches pivotal trial for weight-loss balloon

March 27, 2015 by Mark Hollmer

Armed with a recent $30 million funding found, Obalon Therapeutics launches a pivotal trial for its ingestible weight loss balloon.

Obalon launches pivotal trial for weight-loss balloon

California's Obalon Therapeutics said it launched a pivotal trial set for as many as 15 sites across the U.S. that will test its ingestible, gas-filled weight-loss balloon.

MassDevice.com +3 | The top 3 medtech stories for March 27, 2015

March 27, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

FDA grants exemption for fetal micro-pacemaker

March 27, 2015 by Brad Perriello

The FDA grants a humanitarian device exemption for a micro-pacemaker designed to be implanted in a fetus.

FDA grants exemption for fetal micro-pacemaker

Comparative sizes of fetal
and adult pacemakers.
Click image to enlarge.

Researchers at Children's Hospital Los Angeles and the University of Southern California said the FDA granted a humanitarian device exemption for the fetal micro-pacemaker they designed.

Stryker debuts Osiris bone putty

March 27, 2015 by Mark Hollmer

Stryker launches the Bio4 bone-allograft product made by Osiris Therapeutics at the recent American Academy Of Orthopaedic Surgeons meeting in Las Vegas.

Stryker debuts Osiris bone putty